Chilton Investment Company’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Chilton Investment Company's LLY Position: Q2 2026 in Review
Chilton Investment Company reduced its Eli Lilly (LLY) stake by 4.1% in Q2 2026, selling an estimated $248K and leaving 5,720 shares worth $6.86M. The position accounts for 0.16% of the portfolio, ranked #67.
Chilton Investment Company first reported a position in LLY in Q2 2015 and has held it in 17 quarters since. The position peaked at $10.8M in Q4 2025. 4,645 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Chilton Investment Company held 5,720 shares of Eli Lilly worth $6.86M as of Q2 2026.
- Chilton Investment Company sold 243 Eli Lilly shares in Q2 2026, an estimated $248K.
- Eli Lilly made up 0.16% of Chilton Investment Company's portfolio in Q2 2026, its #67 holding.
- Chilton Investment Company first reported a position in Eli Lilly in Q2 2015 and has held it in 17 quarters since.
- Chilton Investment Company's Eli Lilly position peaked at $10.8M in Q4 2025.
- 4,645 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Chilton Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.